Methoxetamine: Difference between revisions
>White m Text replacement - "{{Main|NMDA receptor antagonist}}" to "{{Further|NMDA receptor antagonist}}" |
>Unity patch |
||
Line 145: | Line 145: | ||
*[[Dissociatives]] | *[[Dissociatives]] | ||
*[[Arylcyclohexylamines]] | *[[Arylcyclohexylamines]] | ||
==External links== | ==External links== | ||
*[http://en.wikipedia.org/wiki/Methoxetamine MXE (Wikipedia)] | *[http://en.wikipedia.org/wiki/Methoxetamine MXE (Wikipedia)] | ||
Line 151: | Line 152: | ||
*[http://factsheet.tripsit.me/mxe MXE (TripSit)] | *[http://factsheet.tripsit.me/mxe MXE (TripSit)] | ||
*[https://www.erowid.org/experiences/subs/exp_Methoxetamine_.shtml MXE experiences (Erowid)] | *[https://www.erowid.org/experiences/subs/exp_Methoxetamine_.shtml MXE experiences (Erowid)] | ||
==Literature== | |||
* Morris, H., & Wallach, J. (2014). From PCP to MXE: A comprehensive review of the non-medical use of dissociative drugs. Drug Testing and Analysis, 6(7–8), 614–632. https://doi.org/10.1002/dta.1620 | |||
==References== | ==References== |